cirazoline has been researched along with oxymetazoline in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batink, H; de Jonge, A; Thoolen, MJ; Timmermans, PB; van Zwieten, PA; Wilffert, B | 1 |
| Esbenshade, TA; Han, C; Hollinger, S; Minneman, KP; Theroux, TL | 1 |
| Berman, J; Bigham, EC; Bishop, MJ; Garrison, DT; Gobel, MJ; Hodson, SJ; Irving, PE; Liacos, JA; Minick, DJ; Navas, F; Saussy, DL; Speake, JD | 1 |
| Bigham, EC; Bishop, MJ; Drewry, DH; Garrison, DT; Gobel, MJ; Hodson, SJ; Irving, PE; Liacos, JH; Navas, F; Saussy, DL; Speake, JD | 1 |
| Agbaba, D; Filipic, S; Nikolic, K | 1 |
| Bronnikov, G; Houstĕk, J; Nedergaard, J | 1 |
| Cavero, I; Gomeni, R; Lefèvre-Borg, F; Roach, AG; Scatton, B | 1 |
| Foglar, R; Horie, K; Obika, K; Tsujimoto, G | 1 |
| Gaivin, RJ; Gonzalez-Cabrera, P; Perez, DM; Ross, SA; Waugh, DJ; Yun, J; Zuscik, MJ | 1 |
| Amobi, N; Guillebaud, J; Kaisary, A; Lloyd-Davies, RW; Smith, IC; Turner, E | 1 |
10 other study(ies) available for cirazoline and oxymetazoline
| Article | Year |
|---|---|
Quantitative relationships between alpha-adrenergic activity and binding affinity of alpha-adrenoceptor agonists and antagonists.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Blood Pressure; Brain; Cell Membrane; Clonidine; Kinetics; Prazosin; Quinazolines; Rats; Receptors, Adrenergic, alpha; Structure-Activity Relationship; Vasoconstriction | 1984 |
Selectivity of agonists for cloned alpha 1-adrenergic receptor subtypes.
Topics: Adrenergic alpha-1 Receptor Agonists; Animals; Binding, Competitive; Catecholamines; Cattle; Cell Line; Cloning, Molecular; Cricetinae; Humans; Imidazoles; Inositol Phosphates; Phenethylamines; Phenoxybenzamine; Radioligand Assay; Rats; Receptors, Adrenergic, alpha-1; Recombinant Proteins; Tetralones | 1994 |
2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Amides; Carboxylic Acids; Esters; Imidazoles; Structure-Activity Relationship | 2001 |
2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Calcium Signaling; Cell Line; Cloning, Molecular; Heterocyclic Compounds; Humans; Imidazoles; Oximes; Phenylephrine; Protein Binding; Rats; Receptors, Adrenergic, alpha-1 | 2002 |
QSAR study of imidazoline antihypertensive drugs.
Topics: Antihypertensive Agents; Binding Sites; Imidazoline Receptors; Imidazolines; Ligands; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship | 2008 |
Beta-adrenergic, cAMP-mediated stimulation of proliferation of brown fat cells in primary culture. Mediation via beta 1 but not via beta 3 adrenoceptors.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adipose Tissue, Brown; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bucladesine; Cell Division; Cells, Cultured; Cholera Toxin; Colforsin; Cyclic AMP; DNA Replication; Imidazoles; Mice; Mice, Inbred Strains; Norepinephrine; Oxymetazoline; Propanolamines; Receptors, Adrenergic, beta; Thymidine | 1992 |
Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats.
Topics: Adrenergic alpha-Agonists; Animals; Blood Pressure; Blood Vessels; Brimonidine Tartrate; Clonidine; Dogs; Female; Heart; Heart Rate; Imidazoles; Male; Norepinephrine; Oxymetazoline; Pentobarbital; Quinoxalines; Rats; Spinal Cord; Synapses; Tachycardia; Vagotomy | 1982 |
Selectivity of the imidazoline alpha-adrenoceptor agonists (oxymetazoline and cirazoline) for human cloned alpha 1-adrenoceptor subtypes.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Calcium; CHO Cells; Cloning, Molecular; Cricetinae; Humans; Imidazoles; Kinetics; Norepinephrine; Oxymetazoline; Phenethylamines; Phenoxybenzamine; Receptors, Adrenergic, alpha-1; Structure-Activity Relationship; Transfection | 1995 |
Phe-308 and Phe-312 in transmembrane domain 7 are major sites of alpha 1-adrenergic receptor antagonist binding. Imidazoline agonists bind like antagonists.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Amino Acid Sequence; Animals; Cell Membrane; Clonidine; Conserved Sequence; Cricetinae; Dihydropyridines; Dioxanes; Humans; Imidazoles; Models, Molecular; Molecular Sequence Data; Oxymetazoline; Phenylalanine; Piperazines; Prazosin; Protein Structure, Secondary; Rats; Receptors, Adrenergic, alpha-1; Structure-Activity Relationship | 2001 |
Contractile actions of imidazoline alpha-adrenoceptor agonists and effects of noncompetitive alpha1-adrenoceptor antagonists in human vas deferens.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Dibenzylchlorethamine; Dose-Response Relationship, Drug; Humans; Imidazoles; Male; Muscle Contraction; Norepinephrine; Oxymetazoline; Phenoxybenzamine; Prazosin; Receptors, Adrenergic, alpha-1; Tetrahydronaphthalenes; Vas Deferens | 2003 |